For IHC, the eyes were rinsed in phosphate-buffered saline (PBS) for a minimum of 1 hour, embedded in low-melt agarose (5%; Sigma, St. Louis, MO) at 41°C, and sectioned at 100 μm with tissue-sectioning equipment (Vibratome; Leica, Lumberton, NJ). Sections were incubated in blocking serum (normal donkey serum 1:20 in PBS, 0.5% bovine serum albumin [BSA], 0.1% Triton X-100, and 0.1% azide [PBTA]) overnight on a rotator at 4°C. Primary antibodies in PBTA were added the following day and placed on a rotator overnight at 4°C. Antibodies to the following proteins were used: GFAP (1:400, rabbit polyclonal; Dako, Carpinteria, CA), vimentin (1:500, goat polyclonal; Santa Cruz Biotechnology, Santa Cruz, CA), S100 (1:1000, rabbit polyclonal; Dako), glutamine synthetase (GS; 1:500, mouse monoclonal; BD Biosciences, San Jose, CA), rod opsin (1:500, mouse monoclonal; gift from Robert Molday, University British Columbia, Vancouver, BC, Canada), heavy and light subunits of neurofilament protein (1:500, mouse monoclonal; Biomeda, Hayward, CA), protein kinase C alpha (PKC, rabbit polyclonal, 1:100; Biomol Research Laboratories, Plymouth Meeting, PA), and laminin (1:25, rabbit polyclonal; Sigma, St. Louis, MO). The following day, primary antibodies were rinsed in PBTA and corresponding secondary antibodies, diluted 1:200, were added and incubated overnight on a rotator at 4°C. Secondary antibodies included donkey-anti–mouse or anti–rabbit conjugated to Cy2 or Cy3 (Jackson ImmunoResearch Laboratories, West Grove, PA). On the last day, sections were rinsed in PBTA and mounted in 5% n-propyl gallate in glycerol on glass slides and sealed with a coverslip. The slides were viewed with a laser scanning confocal microscope (FluoView 500; Olympus, Center Valley, PA). During any session of observation and image collection for a given antibody, black and gain levels were kept constant to allow comparisons of labeling intensity.